Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Journal of the American College of Cardiology
|
April 24, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Marc P Bonaca, Deepak L Bhatt, Tabassome Simon, et al.
Journal of the American College of Cardiology
|
April 3, 2020
Ticagrelor With or Without Aspirin After Complex PCI
George Dangas, Usman Baber, Samin Sharma, et al.
Circulation
|
September 1, 2024
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis
Gianluca Campo, Felix Böhm, Thomas Engstrøm, et al.
European Heart Journal
|
May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
A Michael Lincoff, Matthew Roe, Philip Aylward, et al.
The New England Journal of Medicine
|
March 6, 2023
Transcatheter Repair for Patients with Tricuspid Regurgitation
Paul Sorajja, Brian Whisenant, Nadira Hamid, et al.
European Heart Journal
|
October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Javier Escaned, Davide Cao, Usman Baber, et al.
BMJ (Clinical Research Ed.)
|
June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Journal of the American College of Cardiology
|
February 8, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, Roxana Mehran, Mattia Branca, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial
Usman Baber, Davide Cao, Timothy Collier, et al.
JACC. Cardiovascular Interventions
|
July 9, 2021
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI
Dominick J Angiolillo, Davide Cao, Usman Baber, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Journal of the American College of Cardiology
|
April 24, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Marc P Bonaca, Deepak L Bhatt, Tabassome Simon, et al.
Journal of the American College of Cardiology
|
April 3, 2020
Ticagrelor With or Without Aspirin After Complex PCI
George Dangas, Usman Baber, Samin Sharma, et al.
Circulation
|
September 1, 2024
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis
Gianluca Campo, Felix Böhm, Thomas Engstrøm, et al.
European Heart Journal
|
May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
A Michael Lincoff, Matthew Roe, Philip Aylward, et al.
The New England Journal of Medicine
|
March 6, 2023
Transcatheter Repair for Patients with Tricuspid Regurgitation
Paul Sorajja, Brian Whisenant, Nadira Hamid, et al.
European Heart Journal
|
October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Javier Escaned, Davide Cao, Usman Baber, et al.
BMJ (Clinical Research Ed.)
|
June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Journal of the American College of Cardiology
|
February 8, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, Roxana Mehran, Mattia Branca, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial
Usman Baber, Davide Cao, Timothy Collier, et al.
JACC. Cardiovascular Interventions
|
July 9, 2021
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI
Dominick J Angiolillo, Davide Cao, Usman Baber, et al.
Page
of 7